KESTRA MEDICAL TECHNOLOGIES, LTD. current report, 09 September 2026

Business Context and Reporting Period

This Form 8-K reports the results of the 2026 Annual General Meeting of Shareholders for Kestra Medical Technologies, Ltd., held on September 9, 2026. The company is incorporated in Bermuda and its common shares trade on The Nasdaq Stock Market LLC under the symbol KMTS.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

Shareholder participation was high, with 55,399,491 shares voted, representing approximately 94.53% of the 58,603,121 outstanding shares entitled to vote as of the July 17, 2026 record date.

Proposal 1: Election of Directors

Shareholders elected three Class II directors to serve until the 2029 annual meeting. The vote totals were as follows:

Nominee For Against Abstain Broker Non-Vote
Raymond W. Cohen 37,334,685 10,779,640 34,843 7,259,323
Kevin Reilly 38,900,190 9,204,737 35,241 7,259,323
Traci S. Umberger 38,866,030 9,238,943 35,195 7,259,323

Proposal 2: Ratification of Auditors

Shareholders ratified the appointment of PricewaterhouseCoopers as the independent registered public accounting firm for the fiscal year ending April 30, 2027.

For Against Abstain
55,356,225 8,469 34,797

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.

Key Facts for Investor Verification

  • Verify the total number of shares outstanding and the record date (July 17, 2026) to confirm the 94.53% participation rate.
  • Note the significant number of "Against" votes for the director elections, ranging from approximately 9.2 million to 10.8 million votes.
  • Confirm the tenure of the newly elected directors, which extends until the 2029 annual meeting.
  • Verify the appointment of PricewaterhouseCoopers for the fiscal year ending April 30, 2027.